280 related articles for article (PubMed ID: 34726253)
1. [Retracted] miR‑222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma.
Liu K; Liu S; Zhang W; Ji B; Wang Y; Liu Y
Int J Oncol; 2021 Dec; 59(6):. PubMed ID: 34726253
[TBL] [Abstract][Full Text] [Related]
2. [Retracted] miR‑494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN.
Liu K; Liu S; Zhang W; Jia B; Tan L; Jin Z; Liu Y
Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34850964
[TBL] [Abstract][Full Text] [Related]
3. [Retracted] MiR‑132 inhibits cell proliferation, invasion and migration of hepatocellular carcinoma by targeting PIK3R3.
Liu K; Li X; Cao Y; Ge Y; Wang J; Shi B
Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195847
[TBL] [Abstract][Full Text] [Related]
4. [Retracted] Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells.
Yang Q; Zhang S; Kang M; Dong R; Zhao J
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34278510
[TBL] [Abstract][Full Text] [Related]
5. [Retracted] miR‑154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor.
Pang X; Huang K; Zhang Q; Zhang Y; Niu J
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34132377
[TBL] [Abstract][Full Text] [Related]
6. [Retracted] Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin.
Qu Y; Xia P; Zhang S; Pan S; Zhao J
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34726252
[TBL] [Abstract][Full Text] [Related]
7. [Retracted] miR‑338‑3p suppresses tumor growth of ovarian epithelial carcinoma by targeting Runx2.
Wen C; Liu X; Ma H; Zhang W; Li H
Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195848
[TBL] [Abstract][Full Text] [Related]
8. [Retracted] MicroRNA‑154 functions as a tumor suppressor in osteosarcoma by targeting Wnt5a.
Zhou H; Zhang M; Yuan H; Zheng W; Meng C; Zhao D
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34278509
[TBL] [Abstract][Full Text] [Related]
9. [Retracted] miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6.
Wen Q; Zhao J; Bai L; Wang T; Zhang H; Ma Q
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34080656
[TBL] [Abstract][Full Text] [Related]
10. [Retracted] miR‑133a inhibits cervical cancer growth by targeting EGFR.
Song X; Shi B; Huang K; Zhang W
Oncol Rep; 2021 Jul; 46(2):. PubMed ID: 34080664
[TBL] [Abstract][Full Text] [Related]
11. [Retracted] miR‑137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12.
Dong S; Jin M; Li Y; Ren P; Liu J
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34318908
[TBL] [Abstract][Full Text] [Related]
12. [Retracted] Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma
Liu J; Dong BF; Wang PS; Ren PY; Xue S; Zhang XN; Han Z; Chen G
Oncol Rep; 2022 May; 47(5):. PubMed ID: 35234269
[TBL] [Abstract][Full Text] [Related]
13. [Retracted] miR‑218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin.
Tian H; Hou L; Xiong YM; Huang JX; She YJ; Bi XB; Song XR
Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35039879
[TBL] [Abstract][Full Text] [Related]
14. [Retracted] miR‑363 inhibits the growth, migration and invasion of hepatocellular carcinoma cells by regulating E2F3.
Ye J; Zhang W; Liu S; Liu Y; Liu K
Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34498717
[TBL] [Abstract][Full Text] [Related]
15. [Retracted] Synthetic miR‑145 mimic inhibits multiple myeloma cell growth
Zhang Q; Yan W; Bai Y; Xu H; Fu C; Zheng W; Zhu Y; Ma J
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184081
[TBL] [Abstract][Full Text] [Related]
16. [Retracted] MicroRNA-205 acts as a tumor suppressor in osteosarcoma via targeting RUNX2.
Zhang C; Long F; Wan J; Hu Y; He H
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34109990
[TBL] [Abstract][Full Text] [Related]
17. [Retracted] miR‑365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma.
Liu Y; Zhang W; Liu S; Liu K; Ji B; Wang Y
Oncol Rep; 2022 Nov; 48(5):. PubMed ID: 36102315
[TBL] [Abstract][Full Text] [Related]
18. [Retracted] miR‑138 inhibits gastric cancer growth by suppressing SOX4.
Pang L; Li B; Zheng B; Niu L; Ge L
Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35014683
[TBL] [Abstract][Full Text] [Related]
19. [Retracted] MicroRNA‑128 suppresses cell growth and metastasis in colorectal carcinoma by targeting IRS1.
Wu L; Shi B; Huang K; Fan G
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34278481
[TBL] [Abstract][Full Text] [Related]
20. [Retracted] MicroRNA‑326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 1.
Hu S; Ran Y; Chen W; Zhang Y; Xu Y
Oncol Rep; 2023 May; 49(5):. PubMed ID: 36928745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
